Self-reported symptoms in French primary care SARS-CoV-2 patients: association with gender and age group.
Age
COVID-19
France
gender
primary care
symptoms
Journal
Family practice
ISSN: 1460-2229
Titre abrégé: Fam Pract
Pays: England
ID NLM: 8500875
Informations de publication
Date de publication:
27 Aug 2021
27 Aug 2021
Historique:
entrez:
27
8
2021
pubmed:
28
8
2021
medline:
3
9
2021
Statut:
ppublish
Résumé
The early identification of COVID-19 patients is of outmost importance in the current pandemic. As with other pathogens, presenting symptoms of SARS-CoV-2 may vary, depending on sociodemographic factors. We aimed to describe the clinical characteristics of COVID-19 patients by age/gender and to assess whether the diagnostic performance of these symptoms varied according to these variables. We analysed data from a cross-sectional study involving primary care patients undergoing RT-PCR testing in Lyon, France. Among patients who tested positive, we examined whether there was an association between age/gender and various symptoms. In addition, we calculated the diagnostic performance of the most specific symptoms (smell/taste disorder). Among 1543 consecutive patients, 253 tested positive (16%). There were significant age/gender-related differences in symptoms. In middle-aged women, the diagnostic performance of smell/taste disorders were AUC = 0.65 [95%CI 0.59-0.71] and PPV = 72% [95%CI 53-87%], that is higher than in the entire sample (smell/taste disorders: AUC = 0.59 [95%CI 0.57-0.62] and PPV = 57% [95%CI 47-67%]. In contrast, the negative predictive values of smell/taste disorders were similar in both groups (85% [95%CI 81-89%] for middle-age women and 86% [95%CI 85-88%] for the entire sample). We found significant age/gender-related differences in the clinical characteristics of COVID-19 patients. Screening strategies based on smell/taste disorders performed better in middle-aged women, but could not ensure a diagnosis of COVID-19 in any subgroup of patients. Future diagnostic strategies should use age/gender differentiated approaches.
Identifiants
pubmed: 34448483
pii: 6358431
doi: 10.1093/fampra/cmab009
pmc: PMC8513396
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
i37-i44Informations de copyright
© The Author(s) 2021. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.
Références
JAMA. 2020 Apr 7;323(13):1239-1242
pubmed: 32091533
Am J Geriatr Pharmacother. 2010 Feb;8(1):47-62
pubmed: 20226392
N Engl J Med. 2020 Apr 30;382(18):1708-1720
pubmed: 32109013
Asian Pac J Allergy Immunol. 2020 Jun;38(2):69-77
pubmed: 32563234
CMAJ. 2020 Jun 29;192(26):E702-E707
pubmed: 32461325
J Investig Allergol Clin Immunol. 2020;30(5):346-357
pubmed: 32554337
CJEM. 2020 Sep;22(5):595-602
pubmed: 32507123
Int Forum Allergy Rhinol. 2020 Jul;10(7):806-813
pubmed: 32279441
Laryngoscope. 2007 Feb;117(2):272-7
pubmed: 17277621
J Med Virol. 2020 Jun;92(6):612-617
pubmed: 32108351
Int Forum Allergy Rhinol. 2020 Aug;10(8):955-962
pubmed: 32410386
J Gen Intern Med. 2020 Aug;35(8):2502-2504
pubmed: 32519322
Sci Rep. 2020 Nov 13;10(1):19765
pubmed: 33188232
JAMA Netw Open. 2020 Jun 1;3(6):e2012270
pubmed: 32543702
J Infect. 2020 Dec;81(6):937-943
pubmed: 32998038
Pneumologie. 2019 Oct;73(10):605-616
pubmed: 31622999
JAMA. 2020 Mar 17;323(11):1061-1069
pubmed: 32031570
BMJ. 2020 Dec 2;371:m4529
pubmed: 33268329
J Korean Med Sci. 2020 May 11;35(18):e174
pubmed: 32383370
ORL J Otorhinolaryngol Relat Spec. 2020;82(4):175-180
pubmed: 32526759
N Engl J Med. 2020 Jun 11;382(24):2372-2374
pubmed: 32302078
Curr Allergy Asthma Rep. 2020 Oct 13;20(12):76
pubmed: 33048282
J Infect. 2020 Sep;81(3):411-419
pubmed: 32504743
Clin Geriatr Med. 2016 Aug;32(3):523-38
pubmed: 27394021
J Intern Med. 2020 Sep;288(3):335-344
pubmed: 32352202
Rural Remote Health. 2020 Sep;20(3):6325
pubmed: 32955912
J Biol Regul Homeost Agents. 2020 Apr 07;34(2):339-343
pubmed: 32253888